	From Biopsy to Pathology: A Retrospective Cohort Study of Predictors of Gleason Score Upgrading in Grade Group 1 Prostate Cancer. Cancer Diagn Progn Su HC, Su YC, Lee HY, Juan YS, Wu WJ, Lu K. PMID: 42968951 [PubMed]
	Correction to "Chidamide (a Histone Deacetylase Inhibitor) Plus Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Phase Ib Trial". MedComm (2020) PMID: 42968886 [PubMed]
	Advances in Nanoparticle Technologies for Prostate Cancer Detection and Therapy. DNA Cell Biol Abdullo A, Kenjaev Y, Melibayeva R, Firdavs U, Firuza N, Giyos A. PMID: 42968472 [PubMed - as supplied by publisher]
	Non-Invasive Assessment of Perineural Invasion Density: A Novel Marker for Prognosis and Treatment Stratification in Prostate Cancer. Adv Sci (Weinh) Liu B, Zhang L, Zhu W, Yang M, Liu X, Li X, Qin P, Lin Z, Cai Q, Zheng J, Zhao X, Zou C, Wen X, Xu L, Wu D, Zhang L, Zhang C, Li K, Wang C, Zhong W, Luo Y. PMID: 42966879 [PubMed - as supplied by publisher]
	Bone fractures and prior abiraterone use in men treated with radium-223 plus enzalutamide for castration-resistant prostate cancer with bone metastases: a real-world study. Prostate Cancer Prostatic Dis McKay RR, Lunacsek O, Korn MJ, Raval AD. PMID: 42966775 [PubMed - as supplied by publisher]
	Treatment Effect of Perioperative (Neoadjuvant and Adjuvant) Apalutamide plus Androgen-deprivation Therapy Versus Radical Prostatectomy Alone in Patients with High-risk Localized or Locally Advanced Prostate Cancer from the PROTEUS Substudy. Eur Urol Briganti A, Steuber T, Shore ND, Gleave M, Kretschmer A, Wetherhold L, Efstathiou E, Cahn DJ, Damião R, De La Taille A, Byun SS, Hadaschik BA, Imbroda BH, Soto ÁJ, Merseburger AS, Simone G, Rooney B, Mikerin D, Li Z, Miladinovic B, McCarthy SA, Wildgust M, Mundle SD, Kibel AS, Taplin ME. PMID: 42966675 [PubMed - as supplied by publisher]
	A comparative study of effectiveness and safety of percutaneous cryoablation and microwave ablation of renal cell carcinoma. Clin Imaging Villalobos A, Xing M, Mohnasky M, Dabbous H, Aslanyan L, Lilly M, Bercu Z, Kokabi N. PMID: 42966350 [PubMed - as supplied by publisher]
	Long-Term Outcomes of Focal Irreversible Electroporation for Localized Prostate Cancer: Results of a Prospective Pilot Study With Extended Follow-up. Clin Genitourin Cancer Morozov A, Asali M, Matkovskiy I, Rivas JG, Singla N, Tsoy L, Fisenko E, Spivak L, Lokshin K, Rudenko V, Chinenov D, Barret E, Enikeev D. PMID: 42966034 [PubMed - as supplied by publisher]
	Correlation Between Androgen Receptor Expression and Prognosis in Prostate Cancer Patients: A Retrospective Study. J Vis Exp Lu J, Wu H. PMID: 42965378 [PubMed - indexed for MEDLINE]
	Association of Multimodal Psychological Nursing with Mental Health and Quality of Life in Cancer Patients with Renal Failure Receiving Hemodialysis. J Vis Exp Zhang L, Hu X, Zhang C, Xiong J. PMID: 42965348 [PubMed - indexed for MEDLINE]
	Association of the serum sialic acid-to-albumin ratio with prostate cancer and bone metastasis: a retrospective cross-sectional study. PeerJ Ji Y, Guo C, Zhao Y, Yi L, Liu R, Qiu L, Gu G, Li D. PMID: 42964752 [PubMed - indexed for MEDLINE]
	Association of HSD3B1 rs1047303 polymorphism with prognosis in metastatic prostate cancer: A systematic review and meta-analysis. Biochem Biophys Rep Feng F, Wang Y, Yang F, Nie Y. PMID: 42964743 [PubMed]
	Serial urinary NGAL and CK20 for dynamic cardiovascular risk stratification in non-muscle-invasive bladder cancer: a retrospective clinical cohort study. Front Cardiovasc Med Ma W, Liu Y, Tang L, Ouyang S, Ma Y, Zhang Z, Li Q, Li Z, Li L, Zhao Y. PMID: 42964030 [PubMed]
	The evolving role of perioperative systemic therapy in bladder cancer. Cancer Atiq SO, Anker JF, Miller EJ, Karol AB, Mehrazin R, Sfakianos JP, Galsky MD. PMID: 42963929 [PubMed - indexed for MEDLINE]
	Comparison of HPV Antibodies Measured Prior to Diagnosis of Anal, Cervical, Oropharyngeal, Penile and Vaginal Cancers in the HPV Cancer Cohort Consortium. Int J Cancer Onwuka JU, Nobels MP, Kreimer AR, Schroeder L, Ferreiro-Iglesias A, Agalliu I, Albanes D, Cai Q, D'Souza G, Freedman ND, Giles GG, Hildesheim A, Huang WY, Hveem K, Langseth H, Milne RL, Ness-Jensen E, Schlecht NF, Tinker LF, Ursin G, Visvanathan K, Wassertheil-Smoller S, Weinstein SJ, Zheng W, Nygard M, Johansson M, Waterboer T, Clifford GM, Robbins HA. PMID: 42963861 [PubMed - as supplied by publisher]
	A multilevel intervention to improve adherence to prostate cancer active surveillance versus usual care: results from a pilot randomized controlled trial. BMC Cancer Chen JC, Skolarus TA, Furgal A, Rankin A, Wallner LP, Borza T, Hawley ST, Radhakrishnan A. PMID: 42963760 [PubMed - indexed for MEDLINE]
	PSMA Biology Through the Clinical Lens: Implications for Radioligand Therapy of Prostate Cancer with [(177)Lu]Lu-PSMA-617. Drugs Del Re M, Bauckneht M, Danesi R. PMID: 42963536 [PubMed - as supplied by publisher]
	CT-based multimodal fusion model for preoperative clear cell renal cell carcinoma grading: A multicenter study. Eur J Radiol Wu Y, Wang H, Liu C, Liu M, Yi H, Yu N, Jin B. PMID: 42962514 [PubMed - as supplied by publisher]
	Integrated single-cell and bulk RNA-Seq analysis reveals a LCR-related prognostic signature for precision prognostication and therapeutic stratification in clear cell renal cell carcinoma. Cancer Treat Res Commun Zhong W, Rao R, Zhang J, Cheng M, Wu X. PMID: 42962510 [PubMed - as supplied by publisher]
	Comprehensive Characterization of Crotonylation-Related Long Non-Coding RNAs Reveals a Prognostic Signature and Functional Landscape in Bladder Cancer. J Environ Pathol Toxicol Oncol Zhang W, Zheng K, Peng M, Zhang J, Wang X, Yuan Z. PMID: 42962197 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 182648

Page 1 of 9133



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy